Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis.

Kamat SS, Kumar GS, Koshy AV.

Dent Res J (Isfahan). 2013 May;10(3):321-7.

2.

Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.

Kurokawa H, Matsumoto S, Murata T, Yamashita Y, Tomoyose T, Zhang M, Fukuyama H, Takahashi T.

J Oral Pathol Med. 2003 Oct;32(9):513-21.

PMID:
12969225
3.

Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.

Nanda KD, Ranganathan K, Devi U, Joshua E.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Feb;113(2):245-53. doi: 10.1016/j.tripleo.2011.05.034. Epub 2011 Aug 27.

PMID:
22677743
4.

Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.

Palani J, Lakshminarayanan V, Kannan R.

Indian J Dent Res. 2011 Mar-Apr;22(2):362. doi: 10.4103/0970-9290.84281.

5.

Aberrant DKK3 expression in the oral leukoplakia and oral submucous fibrosis: a comparative immunohistochemical study.

Al-Dhohorah T, Mashrah M, Yao Z, Huang J.

Eur J Histochem. 2016 Jun 16;60(2):2629. doi: 10.4081/ejh.2016.2629.

6.

Cytokeratin expression in oral submucous fibrosis--an immunohistochemical study.

Ranganathan K, Kavitha R, Sawant SS, Vaidya MM.

J Oral Pathol Med. 2006 Jan;35(1):25-32.

PMID:
16393250
7.

Inducible nitric oxide synthase expression is upregulated in oral submucous fibrosis.

Rajendran R, Varkey S.

Indian J Dent Res. 2007 Jul-Sep;18(3):94-100.

8.
9.

Proliferation and apoptosis markers in oral submucous fibrosis.

Ranganathan K, Kavitha R.

J Oral Maxillofac Pathol. 2011 May;15(2):148-53. doi: 10.4103/0973-029X.84478.

10.

Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.

Sudha VM, Hemavathy S.

Indian J Dent Res. 2011 Jul-Aug;22(4):520-5. doi: 10.4103/0970-9290.90286.

11.

[Cell morphometric analysis in oral submucous fibrosis, leukoplakia and squamous cell carcinoma].

Gao S.

Zhonghua Kou Qiang Yi Xue Za Zhi. 1992 May;27(3):145-7, 189. Chinese.

PMID:
1292898
12.

Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.

Tilakaratne WM, Iqbal Z, Teh MT, Ariyawardana A, Pitiyage G, Cruchley A, Stewart JE, Hagi-Pavli E, Lalli A, Waseem A, Parkinson EK, Fortune F.

J Oral Pathol Med. 2008 Jul;37(6):372-7. doi: 10.1111/j.1600-0714.2007.00625.x. Epub 2008 Jan 19.

PMID:
18221327
13.

Computational analysis of p63(+) nuclei distribution pattern by graph theoretic approach in an oral pre-cancer (sub-mucous fibrosis).

Bag S, Conjeti S, Das RK, Pal M, Anura A, Paul RR, Ray AK, Sengupta S, Chatterjee J.

J Pathol Inform. 2013 Dec 31;4:35. doi: 10.4103/2153-3539.124006. eCollection 2013.

14.

Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis.

Jyothi Meka N, Ugrappa S, Velpula N, Kumar S, Naik Maloth K, Kodangal S, Ch L, Goyal S.

J Dent Res Dent Clin Dent Prospects. 2015 Summer;9(3):166-74. doi: 10.15171/joddd.2015.031. Epub 2015 Sep 16.

15.
16.
17.

Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity.

Jackson LL, Wade Z, Hessler RB, Abdelsayed R, Rogers JB, Gourin CG.

Laryngoscope. 2007 May;117(5):868-71.

PMID:
17473685
18.

Reduction of syndecan-1 expression is associated with dysplastic oral epithelium.

Soukka T, Pohjola J, Inki P, Happonen RP.

J Oral Pathol Med. 2000 Aug;29(7):308-13.

PMID:
10947246
19.

[Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].

Kikegawa A.

Kokubyo Gakkai Zasshi. 2001 Mar;68(1):51-9. Japanese.

PMID:
11321806
Items per page

Supplemental Content

Write to the Help Desk